How Are Next-Generation Viral and Non-Viral Vector Delivery Systems Evolving?
Gene delivery vector manufacturing remains a pivotal factor in scaling cell therapy production to meet surging global clinical demand. While adeno-associated virus (AAV) and lentiviral vectors dominate current gene transfer workflows, non-viral delivery platforms like electroporation and lipid nanoparticles (LNPs) are gaining substantial traction. To evaluate vector manufacturing capacity...
0 Commentarii 0 Distribuiri 0 previzualizare